Transient lymphadenopathy during intravenous immunoglobulin (IVIg) in a patient with pemphigus vulgaris-Reference-Cited by-同舟云学术

Transient lymphadenopathy during intravenous immunoglobulin (IVIg) in a patient with pemphigus vulgaris

Published:2021-09 Issue:9 Volume:9 Page:
ISSN:2050-0904
Container-title:Clinical Case Reports
language:en
Short-container-title:Clin Case Rep

Author:

Foulad Delila Pouldar¹^ORCID,Rigas Michael²,Piracha Fawad²,Gupta Meeta²,Nguyen Maisie²,Grando Sergei A.¹,Memon Shehla²

Affiliation:

1. Department of Dermatology University of California Irvine California USA

2. KabaFusion Cerritos California USA

Publisher

Wiley

Subject

General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ccr3.4763

Reference4 articles.

1. Diagnosis and classification of pemphigus and bullous pemphigoid

2. Retrospective analysis of a single‐center clinical experience toward development of curative treatment of 123 pemphigus patients with a long‐term follow‐up: efficacy and safety of the multidrug protocol combining intravenous immunoglobulin with the cytotoxic immunosuppressor and mitochondrion‐protecting drugs

3. Food and Drug Administration USA. “FDA Adverse Events Reporting System (FAERS) Public Database–Octagam Human Immunoglobulin”. FDA Adverse Events Reporting System (FAERS) Public Database 20 Sept. 2020 fis.fda.gov/sense/app/d10be6bb‐494e‐4cd2‐82e4‐0135608ddc13/sheet/45beeb74‐30ab‐46be‐8267‐5756582633b4/state/analysis

4. Frequency of Adverse Events Associated with Intravenous Immunoglobulin Therapy in Patients with Pemphigus or Pemphigoid

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multiple drugs;Reactions Weekly;2022-07